A series of pyrazolopyridine and pyridopyrimidine derivatives 2-6 were newly synthesized using 3,5-bisarylmethylene-1-methylpiperidone as the starting material. The anticancer activities of the synthesized compounds were evaluated using 59 different human tumor cell lines, representing cancers of CNS, ovary, renal, breast, colon, lung, leukemia, and melanoma, prostate as well as kidney. Some of the tested compounds, especially those with a fluorine substituent at the para-position in the phenyl ring and those with a pyridopyrimidine-2-thione with a free -NH or -SH, exhibited greater in vitro anti-tumor activities at low concentrations (log 10 [GI₅₀] = -4.6) against the human tumor cell lines. Additionally, some of the compounds had moderate inhibitory effects on the growth of the cancer cell lines. The detailed synthesis, spectroscopic data and antitumor properties of the synthesized compounds are reported.
Because of the interesting biological activities of aminonaphthoquinones, in this review we survey two classes of amino‐1,4‐naphthoquinones: 2,3‐diamino‐1,4‐naphthoquinone and 2‐amino‐1,4‐naphthoquinone. The review includes synthetic methodologies for these classes in addition to their heterocyclization processes. J. Heterocyclic Chem., (2012).
Various 4p-aryl-5p-phenyl-2p,4p-dihydrospiro[indole-3,3p-[1,2,4]triazol]-2(1H)-ones have been synthesised by reaction of amidrazones with 2-(2-oxoindolin-3-ylidene)malononitrile.
Rapid and Facile Synthesis of Spiro[indole-3,3'-[1,2,4]triazol]-2(1H)-ones. -With a view to obtaining pharmacologically active compounds the title triazoles are prepared. -(MOHAMED, A. M.; ALSHARARI, M. A.; ALY*, A. A.; J. Chem.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.